Dynamic Size‐Change Nanovaccine for Enhancing Lymph Node Deep Penetration and Eliciting Robust Antitumor Immune Responses
- 14 July 2025
- journal article
- Published by Wiley in Advanced Materials
- Vol. 37 (39) , e2504909
Abstract
Breakthrough advances in nanotechnology have substantially enhanced lymph node (LN) targeting efficiency and immune cell uptake of nanovaccines, establishing novel avenues for tumor immunotherapy. Nevertheless, current nanovaccines predominantly accumulate in subcapsular sinuses (SCS) or superficial cortical regions post‐lymphatic transport, failing to traverse anatomical barriers to reach the T cell‐enriched paracortex—a critical delivery bottleneck that severely limits full activation of cellular immunity. Furthermore, the absence of tumor‐specific endogenous stimuli in LN microenvironments invalidates conventional environment‐responsive delivery strategies. Herein, “ d yn a mically s ize‐c h ange nanovaccine” (DashVax), a time‐controlled self‐disassembling nanovaccine is presented that achieves dynamic size transition from 102 to 5 nm via physiologically regulated imine bond hydrolysis. This design capitalizes on the lymphatic drainage superiority of large particles and tissue‐penetrating capacity of small units, achieving a breakthrough 7.3‐fold enhancement in paracortical antigen delivery compared to non‐size‐change nanovaccines (NoncVax). DashVax demonstrates robust antigen‐specific immune responses and tumor growth suppression in both B16‐OVA and MC38 tumor models. This exogenous stimulus‐free temporal delivery strategy not only redefines nanovaccine design principles but also elucidates fundamental correlations between intranodal delivery kinetics and immune activation efficacy.Keywords
Funding Information
- National Natural Science Foundation of China (22222509)
- National Natural Science Foundation of China (22375198)
- National Natural Science Foundation of China (W2412020)
- National Key Research and Development Program of China (2024YFA1212200)
This publication has 49 references indexed in Scilit:
- Topology‐Oriented Lymph Node Drainage of Dendritic Polymer‐TLR Agonist Conjugates to Enhance Vaccine ImmunogenicityAdvanced Materials, 2025
- Minimally Invasive Injectable Gel for Local Immunotherapy of Liver and Gastric CancerAdvanced Science, 2024
- Dynamic Covalent Hydrogel as a Single‐Dose Vaccine Adjuvant for Sustained Antigen Release and Significantly Elevated Humoral ImmunityAdvanced Healthcare Materials, 2024
- A Minimalist Binary Vaccine Carrier for Personalized Postoperative Cancer Vaccine TherapyAdvanced Materials, 2022
- Acidity‐Activatable Dynamic Nanoparticles Boosting Ferroptotic Cell Death for Immunotherapy of CancerAdvanced Materials, 2021
- Endogenous Stimuli‐Activatable Nanomedicine for Immune Theranostics for CancerAdvanced Functional Materials, 2021
- Development of a Cancer Vaccine Using In Vivo Click‐Chemistry‐Mediated Active Lymph Node Accumulation for Improved ImmunotherapyAdvanced Materials, 2021
- Supramolecular Assembled Programmable Nanomedicine As In Situ Cancer Vaccine for Cancer ImmunotherapyAdvanced Materials, 2021
- Choice of Nanovaccine Delivery Mode Has Profound Impacts on the Intralymph Node Spatiotemporal Distribution and Immunotherapy EfficacyAdvanced Science, 2020
- Integration of Nanoassembly Functions for an Effective Delivery Cascade for Cancer DrugsAdvanced Materials, 2014